Affera Global Registry

This is a registry study (data collection only, no experimental treatment) tracking real-world outcomes for patients who undergo a heart ablation procedure using the commercially available Affera Platform — a system used to treat heart rhythm problems (arrhythmias). The goal is to collect long-term safety and effectiveness data from patients in routine clinical care. **You may be eligible if...** - You are 18 years of age or older (or meet your local minimum age requirement) - You are scheduled to have a procedure using the Affera Platform as part of your normal care - You are willing to follow the study requirements and give your consent **You may NOT be eligible if...** - You are already enrolled in another study that hasn't approved combined enrollment - Your local laws or regulations exclude you from participating Talk to your doctor to see if this trial is right for you.